Close Asset Management’s Idexx Laboratories IDXX Stock Holding History

Close Asset Management’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$191K	Buy	363 +50	+16%	+$28K	0.01%	126
2026 Q1	$176K	Hold	313	–	–	﹤0.01%	132
2025 Q4	$212K	Hold	313	–	–	﹤0.01%	130
2025 Q3	$200K	Sell	313 -67	-18%	-$40.7K	﹤0.01%	130
2025 Q2	$204K	Sell	380 -30	-7%	-$14.3K	0.01%	124
2025 Q1	$172K	Hold	410	–	–	﹤0.01%	123
2024 Q4	$170K	Hold	410	–	–	﹤0.01%	124
2024 Q3	$207K	Hold	410	–	–	0.01%	120
2024 Q2	$200K	Hold	410	–	–	0.01%	122
2024 Q1	$221K	Hold	410	–	–	0.01%	119
2023 Q4	$228K	Buy	410 +30	+8%	+$14.1K	0.01%	113
2023 Q3	$166K	Buy	380 +300	+375%	+$150K	0.01%	114
2023 Q2	$40K	Buy	+80	New	+$38.3K	﹤0.01%	165

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Close Asset Management's IDXX Position: Q2 2026 in Review

Close Asset Management increased its Idexx Laboratories (IDXX) stake by 16% in Q2 2026, buying an estimated $28K and bringing the position to 363 shares worth $191K. The position accounts for 0.01% of the portfolio, ranked #126.

Close Asset Management first reported a position in IDXX in Q2 2023 and has held it in 13 quarters since. The position peaked at $228K in Q4 2023. 1,302 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

Close Asset Management held 363 shares of Idexx Laboratories worth $191K as of Q2 2026.
Close Asset Management bought 50 Idexx Laboratories shares in Q2 2026, an estimated $28K.
Idexx Laboratories made up 0.01% of Close Asset Management's portfolio in Q2 2026, its #126 holding.
Close Asset Management first reported a position in Idexx Laboratories in Q2 2023 and has held it in 13 quarters since.
Close Asset Management's Idexx Laboratories position peaked at $228K in Q4 2023.
1,302 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Close Asset Management's 13F filing for Q2 2026, filed 11 Aug 2026.